With an annual turnover of over Rs. 255 crores, Wyeth is the sixth largest pharma MNC in India. It has set up a state-of-art manufacturing facility at Goa.
Wyeth Ltd. was founded on 20th September 1947 as Lederle Laboratories (India) Ltd. as a private limited company. Later, on 31st October 1962, its name was changed to Cyanamid India Limited. In November 1965, it became a private enterprise. With the merger of Geoffrey Manners & Co. Ltd., (GM) with the company on 1st April 2003, the company’s name was changed to Wyeth Limited, and healthcare products became part of the company’s product portfolio. The company has achieved market leadership in the Folic acid, Oral contraceptives and Depilatory cream segment.
Its product portfolio includes therapeutic segments of Anti – Infectives, Vaccines, Oral contraceptives and Hormone Therapy.
For the treatment and prevention of diseases, Wyeth has spent almost US$ 3.1 billion on R&D in vaccine, biopharmaceutical and pharmaceutical segments in 2006. The various therapeutic areas of the company’s business are given below:
- Central Nervous System
- Women’s Health
- Vitamins and Hematinics
- Cardiovascular System
Wyeth provides supportive environment for the overall growth and development of its employees. Competitive compensation, rewarding career and benefit programs are some of the advantages that
the employees enjoy.
RBC, Mahindra Towers,
4th Floor, “A” Wing,
Dr. G. M. Bhosale Road,
Worli, Mumbai – 400018, India. .
Website: www.Wyethindia.com –